ArticlePDF Available

A new method for optimum MRSI of prostate at 3T using adiabatic RF pulses and internal water referencing

Authors:

Abstract

Introduction Proton MR spectroscopic imaging of the prostate has shown clinical potential as an increased ratio between detectable choline plus creatine over citrate levels correlates with the presence of prostate cancer tissue [1-3]. The inherent increase in SNR at higher magnetic field strengths could possibly be used to increase the spatial resolution of the MRSI experiment. The increase in field strength however comes at the expense of higher susceptibility artefacts, which affect the shim quality. This poor shim quality can cause frequency shifts and phase differences between MRSI voxels, which can lead to misinterpretation of MRS resonances obtained from for instance lipids. Prior knowledge of the local frequency offset, line width and phase can improve the fit quality. As citrate and choline can have low SNR, prior knowledge should be obtained from other signals with high SNR, like unsuppressed water. In order to obtain the water signal within the same MRSI sequence, the chemical shift artefact has to be addressed, as the chemical shift difference between the detected metabolites of interest increases from 0.6ppm (choline to citrate 3.2-2.6) to 2.1ppm (water to citrate 4.7-2.6). In this work we used a semi LASER sequence [4] optimized for minimal chemical shift displacement errors, time delays tuned to optimum citrate detection, and MEGA [5] lipid suppression at 3T. Compared to an optimized PRESS sequence [6] without water referencing, the semi LASER sequence enables detection of choline, citrate and water at a lower chemical shift displacement error and with a better citrate line shape. Methods The semi LASER sequence consists of a slice selective 90-degree pulse (4ms) followed by two couples of adiabatic refocusing pulses (each 8ms). The time delays between the pulses are tuned to optimum citrate resonance using a freeware quantum mechanical simulation package (Qsim [7]). The bandwidth of the adiabatic refocusing pulses are calculated using the Bloch equations to determine the chemical shift artefact. A MEGA lipid suppression is integrated in the sequence using a Shinar le Roux optimized chemical shift selective RF pulse of 10ms. The total MRSI sequence (figure 1) is tested in phantoms and validated in several patients, using either an external body array coil or an endorectal coil. Results The quantum mechanical result of the citrate resonance shape using optimized timing of the semi LASER sequence at an echo time of 85 ms is shown in Fig 2a. Phantom results show a similar lineshape (Fig 2b), which is different than the lineshape obtained with an optimized PRESS sequence at an echo time of 145 ms (Fig 2c). The slice profile of the refocusing pulses have a bandwidth of 3200Hz, leading to a chemical shift artefact of +/-4% (Fig 3). 3D MRSI measurements in patients obtained with the optimized semi LASER sequence show unsuppressed water signals next to choline, poli-amines and citrate. Conclusion and discussion These preliminary results indicate that a semi LASER sequence can be used to obtain 3D MRSI data from prostate in vivo with minimal chemical shift artefact. As a consequence of more refocusing pulses compared to a PRESS sequence, the line shape of citrate can be adjusted with more timing variables, which improves the spectral shape. The clinical potential of using water as an internal reference for prior knowledge of frequency, phase and linewidth for fitting of choline and citrate in the improvement of sensitivity is subject to further investigation.30(1):71-80. Fig. 1: Diagram of MRSI pulse sequence using adiabatic slice selective refocusing pulses and MEGA lipid suppression optimized for citrate signal detection.
A preview of the PDF is not available
... For water-unsuppressed 3D MRSI of all patients, we used a semi-LASER sequence with MEGA pulses, in which the water-suppression pulses were removed to allow detection of metabolite peaks simultaneous with the water signal, but still suppressing the lipid peaks. [22][23][24] The MRSI measurements were performed with a TE = 88 ms, TR = 1.35-2.1 seconds, vector size = 2048, and spectral width = 2400 Hz. In the three orthogonal directions, between 10 and 14 phase-encoding steps were applied to each. ...
Article
Full-text available
Purpose Until now, ¹H MRSI of the prostate has been performed with suppression of the large water signal to avoid distortions of metabolite signals. However, this signal can be used for absolute quantification and spectral corrections. We investigated the feasibility of water‐unsuppressed MRSI in patients with prostate cancer for water signal–mediated spectral quality improvement and determination of absolute tissue levels of choline. Methods Eight prostate cancer patients scheduled for radical prostatectomy underwent multi‐parametric MRI at 3 T, including 3D water‐unsuppressed semi‐LASER MRSI. A postprocessing algorithm was developed to remove the water signal and its artifacts and use the extracted water signal as intravoxel reference for phase and frequency correction of metabolite signals and for absolute metabolite quantification. Results Water‐unsuppressed MRSI with dedicated postprocessing produced water signal and artifact‐free MR spectra throughout the prostate. In all patients, the absolute choline tissue concentration was significantly higher in tumorous than in benign tissue areas (mean ± SD: 7.2 ± 1.4 vs 3.8 ± 0.7 mM), facilitating tumor localization by choline mapping. Tumor tissue levels of choline correlated better with the commonly used (choline + spermine + creatine)/citrate ratio (r = 0.78 ± 0.1) than that of citrate (r = 0.21 ± 0.06). The highest maximum choline concentrations occurred in high‐risk cancer foci. Conclusion This report presents the first successful water‐unsuppressed MRSI of the whole prostate. The water signal enabled amelioration of spectral quality and absolute metabolite quantification. In this way, choline tissue levels were identified as tumor biomarker. Choline mapping may serve as a tool in prostate cancer localization and risk scoring in multi‐parametric MRI for diagnosis and biopsy procedures.
Article
Purpose: Volume selection in (1) H MR spectroscopic imaging (MRSI) of the prostate is commonly performed with low-bandwidth refocusing pulses. However, their large chemical shift displacement error (CSDE) causes lipid signal contamination in the spectral range of interest. Application of high-bandwidth adiabatic pulses is limited by radiofrequency (RF) power deposition. In this study, we aimed to provide an MRSI sequence that overcomes these limitations. Methods: Measurements were performed at 3 T with an endorectal receive coil. A semi-LASER sequence was equipped with low RF power demanding gradient-modulated offset-independent adiabaticity (GOIA) refocusing pulses with WURST(16,4) modulation, with a 10 kHz bandwidth. Results: Simulations and phantom studies verified that the GOIA pulses select slices with a flat top and sharp edges and minimal CSDE. The sequence timing was tuned to an optimal citrate signal shape at an echo time of 88 ms. Patient studies (n = 10) demonstrated that high quality spectra with reduced lipid artifacts can be obtained from the whole prostate. Compared with PRESS acquisition at 145 ms the signal-to-noise ratio (SNR) of citrate is increased up to 2.6 and choline up to 1.3. Conclusion: An MRSI sequence of the prostate is presented with minimized spectral lipid contamination and improved SNR, to facilitate routine clinical acquisition of metabolic data. Magn Reson Med 74:915-924, 2015. © 2014 Wiley Periodicals, Inc.
Article
Over the past several years, evidence supporting the use of MR imaging in the evaluation of prostate cancer has grown. Almost all this work has been performed at 1.5T. The gradual introduction of 3T scanners into clinical practice provides a potential opportunity to improve the quality and usefulness of prostate imaging. Increased signal to noise allows for imaging at higher resolution, higher temporal resolution, or higher bandwidth. Although this may improve the quality of conventional T2-weighted prostate imaging, which has been the standard sequence for detecting and localizing prostate cancer for years, the real potential for improvement at 3T involves more advanced techniques, such as spectroscopy, diffusion-weighted imaging, dynamic contrast imaging, and susceptibility imaging. This review presents the current data on 3T MR imaging of the prostate as well as the authors' impressions based on their experience at Yale-New Haven Hospital.
  • J Kurhanewicz
Kurhanewicz J et al. Radiology 1996;198:795-805. 2. Kurhanewicz J et al. Urology 1995;45:459-466. 3. Heerschap A et al. Anticancer Res 1997;17:1455-1460. 4.
  • J Wijnen
Wijnen J et al. ESMRMB annual meeting 2006; 210. 5. Mescher M et al. J Magn Resonan A 1996; 123:226-229. 6. Scheenen TWJ et al. Magn Reson Med 2005;53:1268-1274. 7. Helgstrand M et al. J Biomol NMR. 2004;30(1):71-80.